Florian Weißinger
Impact in
- Oncology top 5%
- CAR-T cell therapy research
- Immunology top 5%
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
Papers in
- Oncology 26
- Neutropenia and Cancer Infections 6
- Epidemiology 12
- Co-authors
- Peter Reimer (11 shared papers)Volker Kunzmann (10 shared papers)Martin Wilhelm (12 shared papers)Thomas Rüediger (4 shared papers)Susanne Eckstein (1 shared paper)Hans‐Peter Tony (1 shared paper)Thomas Rüdiger (5 shared papers)Hans Konrad Müller‐Hermelink (4 shared papers)
- Journals
- Annals of Hematology (12 papers)Blood (10 papers)Journal of Clinical Oncology (5 papers)Neurobiology of Disease (3 papers)Epilepsy & Behavior (2 papers)
- Partner nations
- GermanyUnited StatesUnited Kingdom
In The Last Decade
Florian Weißinger
68 papers receiving 2.6k citations
Peers
Comparison fields: 5 of 112
- Oncology 811
- Immunology 636
- Dermatology 245
- Pathology and Forensic Medicine 436
- Hematology 248
Countries citing papers authored by Florian Weißinger
This map shows the geographic impact of Florian Weißinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Florian Weißinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Florian Weißinger more than expected).
Fields of papers citing papers by Florian Weißinger
This network shows the impact of papers produced by Florian Weißinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Florian Weißinger. The network helps show where Florian Weißinger may publish in the future.
Co-authors
The 25 scholars most cited alongside Florian Weißinger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 73 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 470 | |
| 2 | 2008 | 291 | |
| 3 | 2007 | 206 | |
| 4 | 2003 | 124 | |
| 5 | 2017 | 101 | |
| 6 | 2001 | 90 | |
| 7 | 2007 | 86 | |
| 8 | 2019 | 84 | |
| 9 | 2020 | 84 | |
| 10 | 2015 | 63 | |
| 11 | 2008 | 53 | |
| 12 | 2002 | 52 | |
| 13 | 2015 | 51 | |
| 14 | 2021 | 49 | |
| 15 | 2003 | 48 | |
| 16 | 2006 | 45 | |
| 17 | 2000 | 45 | |
| 18 | 2020 | 44 | |
| 19 | 2004 | 41 | |
| 20 | 2013 | 39 |
About Florian Weißinger
Florian Weißinger is a scholar working on Oncology, Epidemiology, Pathology and Forensic Medicine, Immunology and Cellular and Molecular Neuroscience, having authored 73 papers that have together received 2.6k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (10 papers), Neuroscience and Neuropharmacology Research (7 papers), Epilepsy research and treatment (7 papers), Hematopoietic Stem Cell Transplantation (6 papers), Neutropenia and Cancer Infections (6 papers), Cutaneous lymphoproliferative disorders research (6 papers), Chronic Lymphocytic Leukemia Research (5 papers) and Immunotherapy and Immune Responses (4 papers). The work is most often cited by research in Oncology (811 citations), Immunology (636 citations), Dermatology (245 citations), Pathology and Forensic Medicine (436 citations) and Hematology (248 citations). Florian Weißinger has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Peter Reimer, Volker Kunzmann, Martin Wilhelm, Thomas Rüediger, Susanne Eckstein, Hans‐Peter Tony, Thomas Rüdiger, Hans Konrad Müller‐Hermelink, Hermann Einsele and Martin Wilhelm. Their work appears in journals such as Annals of Hematology, Blood, Journal of Clinical Oncology, Neurobiology of Disease and Epilepsy & Behavior.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.